Genetic variability in morphine sensitivity and tolerance between different strains of rats

Brain Res. 2000 Jun 2;866(1-2):109-15. doi: 10.1016/s0006-8993(00)02255-1.

Abstract

The development of tolerance, the sensitivity to morphine and the effective morphine plasma concentrations have been studied in Sprague-Dawley (SD-U) and Wistar (W) rats. Daily administration of morphine (10 mg/kg/12 h for 9 days) in W rats produced a reduction in morphine antinociception from day 1 (12+/-0 s) to day 9 (6.7+/-1. 9 s). Morphine antinociception in the SD-U rats did not change over the period of treatment. Naloxone abolished the antinociception of morphine in both opiate naive and chronically treated SD-U rats. The pharmacokinetic parameters of morphine and morphine-3-glucuronide did not differ significantly between strains. Both naive and chronically treated SD-U rats required smaller doses of morphine than W rats to obtain a maximum antinociceptive effect. Plasma concentrations following administration of the same dose of morphine, did not differ between strains or days of treatment. The range of morphine concentrations required to obtain a maximum effect were lower in SD-U rats, both on day 1 and day 8 when compared to W rats. These results show differences between the two strains with regard to both morphine sensitivity and development of tolerance, whilst also suggesting that the differences do not have a kinetic basis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Drug Tolerance / genetics*
  • Drug Tolerance / physiology*
  • Male
  • Morphine / pharmacokinetics*
  • Morphine Derivatives / blood
  • Nociceptors / drug effects
  • Nociceptors / metabolism
  • Pain / drug therapy
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Time Factors

Substances

  • Morphine Derivatives
  • Morphine
  • morphine-3-glucuronide